Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000947871-23-000472

10% owner sold 68,481 shares at an average $1.87 ($128,257)

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · 10% owner

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-13 Sale : show line 1 in the form −703 $1.82 $1,279 182,504 I
2023-04-13 Sale : show line 2 in the form −3,784 $1.82 $6,887 981,863 I
2023-04-13 Sale : show line 3 in the form −9,459 $1.82 $17,215 2,454,775 I
2023-04-14 Sale : show line 4 in the form −2,091 $1.86 $3,889 180,413 I
2023-04-14 Sale : show line 5 in the form −11,245 $1.86 $20,916 970,618 I
2023-04-14 Sale : show line 6 in the form −28,110 $1.86 $52,285 2,426,665 I
2023-04-17 Sale : show line 7 in the form −660 $1.97 $1,300 179,753 I
2023-04-17 Sale : show line 8 in the form −3,551 $1.97 $6,995 967,067 I
2023-04-17 Sale : show line 9 in the form −8,878 $1.97 $17,490 2,417,787 I
Open-market sales · 68,481 sh · avg $1.87 · $128,257
Loading xslF345X04/ownership.xml…